Sequanta Technologies, a multi-omics research and clinical service provider based in Shanghai, and Grandomics Biosciences Co., Ltd, a Beijing-based biotech specializing in applying bioinformatics, genomics, and cutting-edge internet technologies to clinical medicine and personal health, have signed a long-term collaboration agreement. The partnership aims to integrate short-read sequencing and long-read sequencing resources to set up an ultra-high throughput integrated sequencing service laboratory in the China (Shanghai) Pilot Free Trade Zone.<\/p>\n\n\n\n